These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3474356)

  • 21. Definition of refractoriness against conventional chemotherapy in acute myeloid leukemia: a proposal based on the results of retreatment by thioguanine, cytosine arabinoside, and daunorubicin (TAD 9) in 150 patients with relapse after standardized first line therapy.
    Hiddemann W; Martin WR; Sauerland CM; Heinecke A; Büchner T
    Leukemia; 1990 Mar; 4(3):184-8. PubMed ID: 2314117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens.
    Zeremski V; Savić A
    Med Pregl; 2014; 67(3-4):83-90. PubMed ID: 24961049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
    Hansen OP; Pedersen-Bjergaard J; Ellegaard J; Brincker H; Boesen AM; Christensen BE; Drivsholm A; Hippe E; Jans H; Jensen KB
    Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital.
    Hurwitz CA; Krance R; Schell MJ; Santana VM; Brenner MK; Ribeirio R; Roberts WM; Mahmoud H; Belt J; Crom W
    Leukemia; 1992; 6 Suppl 2():39-43. PubMed ID: 1374492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside.
    Ghaddar HM; Plunkett W; Kantarjian HM; Pierce S; Freireich EJ; Keating MJ; Estey EH
    Leukemia; 1994 Aug; 8(8):1269-74. PubMed ID: 8057660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive treatment of acute leukemia in adults 70 years of age and older.
    Walters RS; Kantarjian HM; Keating MJ; Estey EH; McCredie KB; Freireich EJ
    Cancer; 1987 Jul; 60(2):149-55. PubMed ID: 3474052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHOP treatment of childhood acute myelogenous leukemia with monocytic differentiation: a report on five cases.
    Urasiński T; Podraza W
    Haematol Blood Transfus; 1987; 30():403-5. PubMed ID: 3476373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study.
    Steuber CP; Civin C; Krischer J; Culbert S; Ragab A; Ruymann FB; Ravindranath Y; Leventhal B; Wilkinson R; Vietti TJ
    J Clin Oncol; 1991 Feb; 9(2):247-58. PubMed ID: 1988573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.
    Dahl GV; Kalwinsky DK; Mirro J; Look AT; Pui CH; Murphy SB; Mason C; Ruggiero M; Schell M; Johnson FL
    J Clin Oncol; 1990 Feb; 8(2):295-303. PubMed ID: 2299372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current results of cooperative AML therapy studies in children: BFM-78 and 83].
    Creutzig U; Ritter J; Budde M; Riehm H; Henze G; Lampert F; Gerein V; Müller-Weihrich S; Niethammer D; Spaar HJ
    Klin Padiatr; 1986; 198(3):183-90. PubMed ID: 3523024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment results in childhood acute myeloblastic leukemia--a report of clinical trials of a past decade from the Japanese children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Hirota T; Mimaya J; Horikoshi Y; Kawamura N; Yanai M; Kamitamari A; Tsuji Y; Fujimoto T
    Rinsho Ketsueki; 1997 Jun; 38(6):505-12. PubMed ID: 9248326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment outcome and prognostic factors in childhood acute myeloblastic leukemia: a report from the Japanese Children's Cancer and Leukemia Study Group (CCLSG).
    Katano N; Tsurusawa M; Hirota T; Horikoshi Y; Mimaya J; Yanai M; Tsuji Y; Fujimoto T
    Int J Hematol; 1997 Jul; 66(1):103-10. PubMed ID: 9220666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
    Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
    Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: a report from the Childrens Cancer Study Group.
    Buckley JD; Lampkin BC; Nesbit ME; Bernstein ID; Feig SA; Kersey JH; Piomelli S; Kim T; Hammond GD
    Med Pediatr Oncol; 1989; 17(5):382-90. PubMed ID: 2677628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.
    Felix A; Leblanc T; Petit A; Nelkem B; Bertrand Y; Gandemer V; Sirvent A; Paillard C; Schmitt C; Rohrlich PS; Fenneteau O; Ragu C; Michel G; Auvrignon A; Baruchel A; Leverger G
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):43-47. PubMed ID: 29189507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia.
    Kalwinsky DK; Raimondi SC; Schell MJ; Mirro J; Santana VM; Behm F; Dahl GV; Williams D
    J Clin Oncol; 1990 Jan; 8(1):75-83. PubMed ID: 2295913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
    Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
    J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in adult patients with acute leukemia.
    Arimori S; Nagao T
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):411-7. PubMed ID: 6242082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute myelogenous leukemia in children.
    Schellong G; Creutzig U; Ritter J
    Med Oncol Tumor Pharmacother; 1985; 2(1):17-25. PubMed ID: 3863999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.